On May 3, 2018 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), reported that the Company will present and meet investors at the 2018 Disruptive Growth and Healthcare Conference in New York City (Press release, Onconova, MAY 3, 2018, View Source [SID1234526084]). Dr. Ramesh Kumar, President & CEO, will present at the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the Presentation:

2018 Disruptive Growth and Healthcare Conference

Reed Smith
599 Lexington Avenue, 22nd Floor
New York, NY 10022

Presentation time: 5:05-5:25 PM EDT (breakout 5:30-05:50 PM)

Presentation room: A/B

The Company is available for investor and partnering meetings